TENT5A (terminal nucleotidyltransferase 5A)
|
Gene
Gene information from NCBI Gene database.
|
|
| Entrez ID | 55603 |
| Gene name | Terminal nucleotidyltransferase 5A |
| Gene symbol | TENT5A |
| Synonyms (NCBI Gene) |
C6orf37FAM46AOI18XTP11
|
| Chromosome | 6 |
| Chromosome location | 6q14.1 |
|
SNPs
SNP information provided by dbSNP.
4
|
|||||||||||||||||||||
|
|||||||||||||||||||||
|
Gene ontology (GO)
Gene Ontology (GO) annotations describing the biological processes, molecular functions, and cellular components associated with a gene.
17
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other IDs provides unique identifiers for this gene in OMIM, HGNC, and Ensembl databases.
|
|||||||
|
|||||||
|
Protein
Protein information from UniProt database.
|
|||||||||||
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q96IP4 | ||||||||||
| Protein name | Terminal nucleotidyltransferase 5A (EC 2.7.7.19) (HBV X-transactivated gene 11 protein) (HBV XAg-transactivated protein 11) | ||||||||||
| Protein function | Cytoplasmic non-canonical poly(A) RNA polymerase that catalyzes the transfer of one adenosine molecule from an ATP to an mRNA poly(A) tail bearing a 3'-OH terminal group and participates in the cytoplasmic polyadenylation (PubMed:33882302). Poly | ||||||||||
| PDB | 8EXE , 8EXF | ||||||||||
| Family and domains |
Pfam
|
||||||||||
| Tissue specificity | TISSUE SPECIFICITY: Widely expressed, with preferential expression observed in the retina compared to other ocular tissues (PubMed:12054608). Also expressed in osteoblasts (PubMed:29358272). {ECO:0000269|PubMed:12054608, ECO:0000269|PubMed:29358272}. | ||||||||||
| Sequence |
|
||||||||||
| Sequence length | 442 | ||||||||||
| Interactions | View interactions | ||||||||||
|
Associated diseases
Disease associations from ClinVar categorized as Causal (Pathogenic/Likely Pathogenic) or Unknown.
19
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||